Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor

por Koblish, Holly K., Wu, Liangxing, Wang, Liang-Chuan S., Liu, Phillip C.C., Wynn, Richard, Rios-Doria, Jonathan, Spitz, Susan, Liu, Hao, Volgina, Alla, Zolotarjova, Nina, Kapilashrami, Kanishk, Behshad, Elham, Covington, Maryanne, Yang, Yan-ou, Li, Jingwei, Diamond, Sharon, Soloviev, Maxim, O'Hayer, Kevin, Rubin, Stephen, Kanellopoulou, Chrysi, Yang, Gengjie, Rupar, Mark, DiMatteo, Darlise, Lin, Luping, Stevens, Christina, Zhang, Yue, Thekkat, Pramod, Geschwindt, Ryan, Marando, Cindy, Yeleswaram, Swamy, Jackson, Jeff, Scherle, Peggy, Huber, Reid, Yao, Wenqing, Hollis, Gregory
Publicado 2022

Standards for educational and psychological testing

por American Educational Research Association
Publicado 2014

S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes

por Lin, Cindy, Garcia-Gerique, Laura, Bonner, Erin E., Mastio, Jerome, Rosenwasser, Matthew, Cruz, Zachary, Lawler, Michael, Bernabei, Luca, Muthumani, Kar, Liu, Qin, Poncz, Mortimer, Vogl, Thomas, Törngren, Marie, Eriksson, Helena, Vogl, Dan T., Gabrilovich, Dmitry I., Nefedova, Yulia
Publicado 2023

Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer

por Sokač, Mateo, Ahrenfeldt, Johanne, Litchfield, Kevin, Watkins, Thomas B.K., Knudsen, Michael, Dyrskjøt, Lars, Jakobsen, Martin R., Birkbak, Nicolai J.
Publicado 2022

Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal Cancer

por Graf, Ryon P., Fisher, Virginia, Creeden, James, Schrock, Alexa B., Ross, Jeffrey S., Nimeiri, Halla, Oxnard, Geoffrey R., Klempner, Samuel J.
Publicado 2022

Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis

por Hoskin, Victoria, Ghaffari, Abdi, Laight, Brian J., SenGupta, Sandip, Madarnas, Yolanda, Nicol, Christopher J.B., Elliott, Bruce E., Varma, Sonal, Greer, Peter A.
Publicado 2022

Chemical, Molecular, and Single-nucleus Analysis Reveal Chondroitin Sulfate Proteoglycan Aberrancy in Fibrolamellar Carcinoma

por Francisco, Adam B., Li, Jine, Farghli, Alaa R., Kanke, Matt, Shui, Bo, Munn, Paul R., Grenier, Jennifer K., Soloway, Paul D., Wang, Zhangjie, Reid, Lola M., Liu, Jian, Sethupathy, Praveen
Publicado 2022

Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles

por Xu, Yitian, Zhang, Licheng, Thaiparambil, Jose, Mai, Sunny, Perera, Dimuthu Nuwan, Zhang, Jilu, Pan, Ping-Ying, Coarfa, Cristian, Ramos, Kenneth, Chen, Shu-Hsia, El-Zein, Randa
Publicado 2022

Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate Cancer

por Alizadeh-Ghodsi, Mohammadreza, Owen, Katie L., Townley, Scott L., Zanker, Damien, Rollin, Samuel P.G., Hanson, Adrienne R., Shrestha, Raj, Toubia, John, Gargett, Tessa, Chernukhin, Igor, Luu, Jennii, Cowley, Karla J., Clark, Ashlee, Carroll, Jason S., Simpson, Kaylene J., Winter, Jean M., Lawrence, Mitchell G., Butler, Lisa M., Risbridger, Gail P., Thierry, Benjamin, Taylor, Renea A., Hickey, Theresa E., Parker, Belinda S., Tilley, Wayne D., Selth, Luke A.
Publicado 2022

An Informatics Bridge to Improve the Design and Efficiency of Phase I Clinical Trials for Anticancer Drug Combinations

por Wang, Lei, Wei, Lai, Zhang, Shijun, Cheng, Lijun, Shendre, Aditi, Carson, Williams, Chen, James L., Owen, Dwight, Gregory, Megan, Li, Lang
Publicado 2022

Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer

por Eisner, Joel R., Beebe, Kirk D., Mayhew, Gregory M., Shibata, Yoichiro, Guo, Yuelong, Farhangfar, Carol, Farhangfar, Farhang, Uronis, Joshua M., Mooney, Jill, Milburn, Michael V., Foureau, David, White, Richard L., Amin, Asim, Milla, Marcos E.
Publicado 2022

A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma

por Blum, Kristie A., Supko, Jeffrey G., Maris, Michael B., Flinn, Ian W., Goy, Andre, Younes, Anas, Bobba, Suresh, Senderowicz, Adrian M., Efuni, Sergey, Rippley, Ronda, Colak, Gozde, Trojer, Patrick, Abramson, Jeremy S.
Publicado 2022

Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy

por Basseville, Agnes, Cordier, Chiara, Ben Azzouz, Fadoua, Gouraud, Wilfried, Lasla, Hamza, Panloup, Fabien, Campone, Mario, Jézéquel, Pascal
Publicado 2022

A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination

por Birtel, Matthias, Voss, Ralf-Holger, Reinhard, Katharina, Rengstl, Benjamin, Ouchan, Yasmina, Michel, Kristina, Hayduk, Nina, Tillmann, Bodo, Becker, René, Suchan, Martin, Theobald, Matthias, Oehm, Petra, Türeci, Özlem, Sahin, Ugur
Publicado 2022

TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies

por Carideo Cunniff, Elizabeth, Sato, Yosuke, Mai, Doanh, Appleman, Vicky A., Iwasaki, Shinji, Kolev, Vihren, Matsuda, Atsushi, Shi, Judy, Mochizuki, Michiyo, Yoshikawa, Masato, Huang, Jian, Shen, Luhua, Haridas, Satyajeet, Shinde, Vaishali, Gemski, Chris, Roberts, Emily R., Ghasemi, Omid, Bazzazi, Hojjat, Menon, Saurabh, Traore, Tary, Shi, Pu, Thelen, Tennille D., Conlon, Joseph, Abu-Yousif, Adnan O., Arendt, Christopher, Shaw, Michael H., Okaniwa, Masanori
Publicado 2022

Identification of Drug–Cancer Associations: A Nationwide Screening Study

por Kristensen, Kasper Bruun, Friis, Søren, Lund, Lars Christian, Hallas, Jesper, Cardwell, Chris R., Andreassen, Bettina K., Habel, Laurel A., Pottegård, Anton
Publicado 2022

ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell–mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric Cancer Models

por Konno, Hiroyasu, Lin, Tracey, Wu, Renyi, Dai, Xinchuan, Li, Shou, Wang, Grace, Chen, Min, Li, Wenying, Wang, Lina, Sun, Bee-Chun, Luo, Zhen, Huang, Tom, Chen, Yuping, Zhang, John, Ye, Qiuping, Bellovin, David, Wan, Bing, Kang, Lishan, Szeto, Christopher, Hsu, Karl, Kabbarah, Omar
Publicado 2022

A Phase IB Trial of the PI3K Inhibitor Alpelisib and Weekly Cisplatin in Patients with Solid Tumor Malignancies

por Tsang, Erica S., Aggarwal, Rahul R., Dhawan, Mallika S., Bergsland, Emily K., Alvarez, Edwin A., Calabrese, Susan, Pacaud, Romain, Garcia, Jose, Fattah, Delaire, Thomas, Scott, Grabowsky, Jennifer, Moasser, Mark M., Munster, Pamela N.
Publicado 2022